170 related articles for article (PubMed ID: 33788763)
1. Neutrophil-to-lymphocyte Ratio as a Predictor of Malignancy of Intraductal Papillary Mucinous Neoplasms.
Sugimachi K; Mano Y; Matsumoto Y; Nakanoko T; Uehara H; Nakashima Y; Sugiyama M; Ota M; Morita M; Toh Y
Anticancer Res; 2021 Mar; 41(3):1663-1669. PubMed ID: 33788763
[TBL] [Abstract][Full Text] [Related]
2. Carbohydrate Antigen 19-9 Is an Invasive Malignancy Preoperative Prognostic Factor for Intraductal Papillary Mucinous Neoplasms.
Suzuki S; Shimoda M; Shimazaki J; Oshiro Y; Nishda K; Orimoto N; Nagakawa Y; Tsuchida A
Eur Surg Res; 2021; 62(4):262-270. PubMed ID: 34344012
[TBL] [Abstract][Full Text] [Related]
3. Histopathological evaluation of resected intraductal papillary mucinous neoplasms reveals distinct patterns of invasion in associated carcinomas.
Rift CV; Lund EL; Scheie D; Hansen CP; Hasselby JP
Hum Pathol; 2021 Jul; 113():47-58. PubMed ID: 33915115
[TBL] [Abstract][Full Text] [Related]
4. Surgical strategy for intraductal papillary mucinous neoplasms of the pancreas.
Hirono S; Yamaue H
Surg Today; 2020 Jan; 50(1):50-55. PubMed ID: 31807871
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic and Prognostic Impact of Neutrophil-to-Lymphocyte Ratio for Intraductal Papillary Mucinous Neoplasms of the Pancreas With High-Grade Dysplasia and Associated Invasive Carcinoma.
Hata T; Mizuma M; Motoi F; Ishida M; Morikawa T; Takadate T; Nakagawa K; Hayashi H; Kanno A; Masamune A; Kamei T; Furukawa T; Naitoh T; Unno M
Pancreas; 2019 Jan; 48(1):99-106. PubMed ID: 30540681
[TBL] [Abstract][Full Text] [Related]
6. Neutrophil-to-lymphocyte ratio and mural nodule height as predictive factors for malignant intraductal papillary mucinous neoplasms.
Watanabe Y; Niina Y; Nishihara K; Okayama T; Tamiya S; Nakano T
Acta Chir Belg; 2018 Aug; 118(4):239-245. PubMed ID: 29334845
[TBL] [Abstract][Full Text] [Related]
7. Neutrophil-to-Lymphocyte Ratio as a Predictor of Invasive Carcinoma in Patients With Intraductal Papillary Mucinous Neoplasms of the Pancreas.
McIntyre CA; Pulvirenti A; Lawrence SA; Seier K; Gonen M; Balachandran VP; Kingham TP; DʼAngelica MI; Drebin JA; Jarnagin WR; Allen PJ
Pancreas; 2019 Jul; 48(6):832-836. PubMed ID: 31210665
[TBL] [Abstract][Full Text] [Related]
8. Intraductal papillary mucinous neoplasms of the pancreas: an updated experience.
Sohn TA; Yeo CJ; Cameron JL; Hruban RH; Fukushima N; Campbell KA; Lillemoe KD
Ann Surg; 2004 Jun; 239(6):788-97; discussion 797-9. PubMed ID: 15166958
[TBL] [Abstract][Full Text] [Related]
9. The Neutrophil-to-Lymphocyte Ratio Predicts Malignant Potential in Intraductal Papillary Mucinous Neoplasms.
Arima K; Okabe H; Hashimoto D; Chikamoto A; Kuroki H; Taki K; Kaida T; Higashi T; Nitta H; Komohara Y; Beppu T; Takeya M; Baba H
J Gastrointest Surg; 2015 Dec; 19(12):2171-7. PubMed ID: 26443528
[TBL] [Abstract][Full Text] [Related]
10. Prognostic impact of para-aortic lymph node status in resected pancreatic ductal adenocarcinoma and invasive intraductal papillary mucinous neoplasm - Time to consider a reclassification?
Linder S; Holmberg M; Engstrand J; Ghorbani P; Sparrelid E
Surg Oncol; 2022 May; 41():101735. PubMed ID: 35287096
[TBL] [Abstract][Full Text] [Related]
11. Preoperative risk prediction for intraductal papillary mucinous neoplasms by quantitative CT image analysis.
Attiyeh MA; Chakraborty J; Gazit L; Langdon-Embry L; Gonen M; Balachandran VP; D'Angelica MI; DeMatteo RP; Jarnagin WR; Kingham TP; Allen PJ; Do RK; Simpson AL
HPB (Oxford); 2019 Feb; 21(2):212-218. PubMed ID: 30097414
[TBL] [Abstract][Full Text] [Related]
12. High-Grade Dysplasia in Resected Main-Duct Intraductal Papillary Mucinous Neoplasm (MD-IPMN) is Associated with an Increased Risk of Subsequent Pancreatic Cancer.
Majumder S; Philip NA; Singh Nagpal SJ; Takahashi N; Mara KC; Kendrick ML; Smyrk TC; Zhang L; Levy MJ; Gleeson FC; Petersen BT; Pearson RK; Topazian MD; Vege SS; Chari ST
Am J Gastroenterol; 2019 Mar; 114(3):524-529. PubMed ID: 30413822
[TBL] [Abstract][Full Text] [Related]
13. Independent predictors of secondary invasive pancreatic remnant tumors after initial resection of an intraductal papillary mucinous neoplasm: a nationwide large-scale survey in Japan.
Takigawa Y; Kitago M; Matsui J
Surg Today; 2020 Dec; 50(12):1672-1680. PubMed ID: 32661567
[TBL] [Abstract][Full Text] [Related]
14. [The value of preoperative CA19-9 combined with platelet-to-lymphocyte ratio in predicting invasive malignancy in intraductal papillary mucinous neoplasms].
Li JA; Han X; Fang Y; Zhang L; Lou WH; Xu XF; Wu WC; Kuang TT; Wang DS; Rong YF
Zhonghua Wai Ke Za Zhi; 2019 Mar; 57(3):170-175. PubMed ID: 30861644
[No Abstract] [Full Text] [Related]
15. Prognostic impact of conservative surgery for pancreatic IPMNs.
Palmeri M; Di Franco G; Bianchini M; Guadagni S; Gianardi D; Furbetta N; Caprili G; Fatucchi LM; Sbrana A; Funel N; Pollina LE; Di Candio G; Morelli L
Surg Oncol; 2021 Sep; 38():101582. PubMed ID: 33892432
[TBL] [Abstract][Full Text] [Related]
16. MUC2 expression and prevalence of high-grade dysplasia and invasive carcinoma in mixed-type intraductal papillary mucinous neoplasm of the pancreas.
Masuda A; Arisaka Y; Hara S; Matsumoto I; Takenaka M; Sakai A; Shiomi H; Matsuki N; Sugimoto M; Fujita T; Hayakumo T; Ku Y; Ogino S; Azuma T; Kutsumi H
Pancreatology; 2013; 13(6):583-8. PubMed ID: 24280573
[TBL] [Abstract][Full Text] [Related]
17. Significance of pancreatic calcification on preoperative computed tomography of intraductal papillary mucinous neoplasms.
Tsujimae M; Masuda A; Shiomi H; Toyama H; Sofue K; Ueshima E; Yamakawa K; Ashina S; Yamada Y; Tanaka T; Tanaka S; Nakano R; Sato Y; Ikegawa T; Kurosawa M; Fujigaki S; Kobayashi T; Sakai A; Kutsumi H; Zen Y; Itoh T; Fukumoto T; Kodama Y
J Gastroenterol Hepatol; 2019 Sep; 34(9):1648-1655. PubMed ID: 31111533
[TBL] [Abstract][Full Text] [Related]
18. Recurrence patterns after surgical resection of intraductal papillary mucinous neoplasm (IPMN) of the pancreas; a multicenter, retrospective study of 1074 IPMN patients by the Japan Pancreas Society.
Hirono S; Shimizu Y; Ohtsuka T; Kin T; Hara K; Kanno A; Koshita S; Hanada K; Kitano M; Inoue H; Itoi T; Ueki T; Shimokawa T; Hijioka S; Yanagisawa A; Nakamura M; Okazaki K; Yamaue H
J Gastroenterol; 2020 Jan; 55(1):86-99. PubMed ID: 31463655
[TBL] [Abstract][Full Text] [Related]
19. What is the Incidence of Malignancy in Resected Intraductal Papillary Mucinous Neoplasms? An Analysis of Over 100 US Institutions in a Single Year.
Khoury RE; Kabir C; Maker VK; Banulescu M; Wasserman M; Maker AV
Ann Surg Oncol; 2018 Jun; 25(6):1746-1751. PubMed ID: 29560572
[TBL] [Abstract][Full Text] [Related]
20. Neutrophil-to-lymphocyte Ratio is a Predictive Marker for Invasive Malignancy in Intraductal Papillary Mucinous Neoplasms of the Pancreas.
Gemenetzis G; Bagante F; Griffin JF; Rezaee N; Javed AA; Manos LL; Lennon AM; Wood LD; Hruban RH; Zheng L; Zaheer A; Fishman EK; Ahuja N; Cameron JL; Weiss MJ; He J; Wolfgang CL
Ann Surg; 2017 Aug; 266(2):339-345. PubMed ID: 27631774
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]